Home
 
Email Newsletter icon, E-mail Newsletter icon, Email List icon, E-mail List icon Sign up for our Email Newsletter
 
Apredica: Early ADME Tox / ADMET Contract Research

                    Preclinical ADME Tox Contract Research

Apredica provides preclinical contract testing services for the evaluation and optimization of the ADME Tox (including cardiac toxicity) and Pharmacokinetic properties of drug candidates early in the drug-discovery process.

Contact our client services department to learn more about how Apredica can assist with your company's preclinical ADME Tox, hERG, and PK issues.

Vendors and other inquires contact us here.

Why Apredica for Preclinical ADME Tox?

Apredica maximizes your speed and efficiency.

  • Scientist-to-Scientist Communications
    Nothing is more frustrating to high-level scientists than to have to communicate through non-scientific sales and service personnel to get science done. That's why all accounts with Apredica are served by Scientist Study Managers working in the lab on your ADME Tox research.

  • Fast Turnaround
    The direction taken by medicinal chemistry is substantially influenced by ADME Tox results. While your medicinal chemists are waiting for ADME Tox results, they could be wasting time following a dead-end lead. Apredica will provide ADME Tox assay results for you in just days. And for increased speed and convenience, if you're in the greater Boston area we'll even send a courier to pick up your samples.

  • Service Focus
    Some CROs have their own drug-discovery programs that may distract them from servicing clients or even pose a risk to your intellectual property. The only drug-discovery programs Apredica advances are those of our clients.

  • Expertise
    Apredica's scientific team all each have more than 10 years drug-discovery experience. 80% of our scientific staff have Ph.D.s.

Contact our client services department to discuss how Apredica's ADME Tox testing services can help your organization increase the speed of drug discovery while reducing costs. Ask about Apredica's ADDMEsm approach for Avoiding Drug Develoment Mistakes Early.

Vendors and other inquires contact us here.




solubility • chemical stability • metabolic stability • metabolite ID • protein binding • cyp inhibition & induction • DMPK • cell-based toxicity • in vivo bioanalysis • LV/UV & LC/MS/MS method development • caco-2 permeability